跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Hospira Dacarbazine for Injection USP, 200 mg vial
Approved
STANDARD
Hospira Dacarbazine for Injection USP, 200 mg vial
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e311764f05ee7b2b
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e311764f05ee7b2b
Product Name
Hospira Dacarbazine for Injection USP, 200 mg vial
Artg Id
142149
Artg Name
Hospira Dacarbazine for Injection USP, 200 mg vial
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2007-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e311764f05ee7b2b
Type
Standard
Back to TGA Approvals
Hospira Dacarbazine for Injection USP, 200 mg vial - TGA Drug Approval Details
